ADVIA CENTAUR HCV ON CENTAUR CP

Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus

FDA Premarket Approval P030056 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the transition of the advia centaur hcv assay to a new platform in the centaur family of instruments, the centaur cp. Advia centaur hcv readypack reagents on the centaur cp analyzerthe advia centaur hcv assay is an in vitro diagnostic immunoassay for the qualitativedetermination of immunoglobulin g (igg) antibodies to hepatitis c virus (hcv) in human serum and plasma (edta, lithium or sodium heparinized) using the advia centaur cp system. The assay may be used in conjunction with other serological and clinical information to aid in thediagnosis of individuals with symptoms of hepatitis and in individuals at risk for hepatitis cinfection. Advia centaur hcv quality controls on the centaur cp analyzerthe advia centaur hcv quality controls are intended for in vitro diagnostic use inmonitoring the performance of the hcv assay on the advia centaur systems. The performance of the hcv quality controls has not been established with any other anti-hcv assay.

DeviceADVIA CENTAUR HCV ON CENTAUR CP
Classification NameAssay, Enzyme Linked Immunosorbent, Hepatitis C Virus
Generic NameAssay, Enzyme Linked Immunosorbent, Hepatitis C Virus
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS
Date Received2008-08-25
Decision Date2009-08-13
PMAP030056
SupplementS002
Product CodeMZO
Advisory CommitteeMicrobiology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516

Supplemental Filings

Supplement NumberDateSupplement Type
P030056Original Filing
S020 2021-04-01 30-day Notice
S019 2020-12-22 Real-time Process
S018 2020-07-31 30-day Notice
S017 2020-05-22 30-day Notice
S016 2020-03-09 30-day Notice
S015 2020-02-21 30-day Notice
S014 2019-02-01 30-day Notice
S013 2018-07-19 Real-time Process
S012
S011 2017-09-29 Normal 180 Day Track
S010 2015-06-11 30-day Notice
S009 2015-05-01 Normal 180 Day Track
S008 2014-09-15 Normal 180 Day Track
S007 2012-03-26 Normal 180 Day Track No User Fee
S006 2009-05-18 Normal 180 Day Track
S005 2009-03-31 Normal 180 Day Track
S004 2009-03-09 Normal 180 Day Track No User Fee
S003 2009-02-04 30-day Notice
S002 2008-08-25 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
00630414597867 P030056 002
00630414473161 P030056 002
00630414278759 P030056 002
00630414278742 P030056 002
00630414301341 P030056 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.